Hydrogen + Carbon Compounds (H + C)
Found 986,543 compounds containing Hydrogen + Carbon. Page 1190 of 19731.
H
Hydrogen
Lightest element, forms water with oxygen
C
Carbon
Basis of organic chemistry
| Formula | IUPAC Name | Common Name | Mol. Weight |
|---|---|---|---|
| C14H15N3O5 | 2-cyano-3-[5-(dihydroxyamino)-3,4-dioxo-cyclohexa-1,5-dien-1-yl]-N,N-diethyl-prop-2-enamide | 2-cyano-3-[5-(dihydroxyamino)-3,4-dioxo-cyclohexa-1,5-dien-1-yl]-N,N-diethyl-prop-2-enamide | 305.29 |
| C20H34N5O10-3 | 2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate | 2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate | 504.50 |
| C20H37N5O10 | 2-[bis[2-[carboxymethyl-[2-(2-methoxyethylamino)-2-oxo-ethyl]amino]ethyl]amino]acetic acid | Versetamide | 507.50 |
| C26H45NO8 | [(2R,3R,4R,5S)-3,4,5-tri(butanoyloxy)-1-butyl-2-piperidyl]methyl butanoate | Glycovir | 499.60 |
| C9H20N2O3Pt | [2-(aminomethyl)cyclobutyl]methanamine;2-hydroxypropanoic acid;platinum | F77296 | 399.35 |
| C14H23N3OS | 3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole | XANOMELINE | 281.42 |
| C28H30FN3OS | N-(6,11-dihydrobenzo[c][1]benzothiepin-11-yl)-4-[4-(4-fluorophenyl)piperazin-1-yl]butanamide | Monatepil | 475.60 |
| C11H13F3OSi | 2,2,2-trifluoro-1-(3-trimethylsilylphenyl)ethanone | ZIFROSILONE | 246.30 |
| C15H23Cl3N6 | 2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine;dihydrochloride | LESOPITRON DIHYDROCHLORIDE | 393.70 |
| C15H21ClN6 | 2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine | Lesopitron | 320.82 |
| C20H29ClN2O5 | methyl 1-(3-methoxy-3-oxo-propyl)-4-(N-propanoylanilino)piperidine-4-carboxylate;hydrochloride | REMIFENTANIL HYDROCHLORIDE | 412.90 |
| C20H28N2O5 | methyl 1-(3-methoxy-3-oxo-propyl)-4-(N-propanoylanilino)piperidine-4-carboxylate | REMIFENTANIL | 376.40 |
| C18H25N3O | 4,6-dimethyl-2-(6-phenylhexylamino)pyrimidin-5-ol | enazadrem | 299.40 |
| C12H11N5O | 2-amino-7-(3-pyridylmethyl)-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | 2-amino-7-(3-pyridylmethyl)-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | 241.25 |
| C16H30O6 | (1R)-1-[(3aR,5R,6S,6aR)-6-heptoxy-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol | SEPRILOSE | 318.41 |
| C30H41N3O6 | [3-[[4-(2-isopropoxyphenyl)piperazin-1-yl]methyl]phenyl]-(1-piperidyl)methanone;succinic acid | MAZAPERTINE SUCCINATE | 539.70 |
| C26H35N3O2 | [3-[[4-(2-isopropoxyphenyl)piperazin-1-yl]methyl]phenyl]-(1-piperidyl)methanone | Mazapertine | 421.60 |
| C30H46O3 | trans-(1R,3S)-5-[2-[(1R,3aS,7aR)-1-[(1R)-6-ethyl-6-hydroxy-1-methyl-octa-2,4-dienyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol | trans-(1R,3S)-5-[2-[(1R,3aS,7aR)-1-[(1R)-6-ethyl-6-hydroxy-1-methyl-octa-2,4-dienyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol | 454.70 |
| C66H68CaF2N4O10 | calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate) | ATORVASTATIN CALCIUM | 1155.30 |
| C33H35FN2O5 | (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid | atorvastatin | 558.60 |
| C15H18F3NO5 | (5R)-5-(methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxy-butoxy]phenyl]oxazolidin-2-one | BEFLOXATONE | 349.30 |
| C8H11N3O3S | 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one | lamivudine | 229.26 |
| C17H40N4 | N,N'-bis[3-(ethylamino)propyl]heptane-1,7-diamine | Beph-3 | 300.50 |
| C14H7ClFN2NaO3S | sodium 1-carbamoyl-6-chloro-5-fluoro-3-(thiophene-2-carbonyl)indol-2-olate | sodium 1-carbamoyl-6-chloro-5-fluoro-3-(thiophene-2-carbonyl)indol-2-olate | 360.70 |
| C14H8ClFN2O3S | 6-chloro-5-fluoro-2-hydroxy-3-(thiophene-2-carbonyl)indole-1-carboxamide | Ilonidap | 338.70 |
| C12H15F2NO2 | (2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-morpholin-2-ol | Manifaxine | 243.25 |
| C19H22BrNO4S2 | (9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-bis(2-thienyl)acetate bromide | (9,9-Dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide | 472.40 |
| C19H22NO4S2+ | (9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-bis(2-thienyl)acetate | SCHEMBL411429 | 392.50 |
| C18H21N3O2 | 3-[(4,7-dimethyl-1,3-benzoxazol-2-yl)methylamino]-5-ethyl-6-methyl-1H-pyridin-2-one | 135525-77-8 | 311.40 |
| C18H24N2O3 | 5-[4-methoxy-3-[(2S)-norbornan-2-yl]oxy-phenyl]hexahydropyrimidin-2-one | 135637-46-6 | 316.40 |
| C18H20ClNOS | (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine;hydrochloride | DULOXETINE HYDROCHLORIDE | 333.90 |
| C18H19NOS | (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine | duloxetine | 297.40 |
| C25H25NO4 | N-(3-acetyl-2-hydroxy-phenyl)-4-(4-phenylbutoxy)benzamide | N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | 403.50 |
| C33H45ClN4O9 | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate;trihydrate;hydrochloride | Camptosar | 677.20 |
| C33H38N4O6 | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate | irinotecan | 586.70 |
| C20H22ClN3 | 1-(3-ethylphenyl)-1-methyl-2-(1-naphthyl)guanidine;hydrochloride | Cerestat | 339.90 |
| C20H21N3 | 1-(3-ethylphenyl)-1-methyl-2-(1-naphthyl)guanidine | Aptiganel | 303.40 |
| C28H42N2O5S | 2-azaniumylethylammonium;(2S,3R)-3-(2-carboxylatoethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoate | 2-azaniumylethylammonium;(2S,3R)-3-(2-carboxylatoethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoate | 518.70 |
| C26H34O5S | (2S,3R)-3-(2-carboxyethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoic acid | Pobilukast | 458.60 |
| C20H21N5O6 | (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid | (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid | 427.40 |
| C27H34N4O4 | 2-benzamidoacetic acid;4-(dipropylamino)-1,3,4,5-tetrahydrobenzo[cd]indole-6-carboxamide | AC1Q5WNG | 478.60 |
| C18H25N3O | 4-(dipropylamino)-1,3,4,5-tetrahydrobenzo[cd]indole-6-carboxamide | LY 178210 | 299.40 |
| C24H29N5O3 | (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid | valsartan | 435.50 |
| C22H29N5O5S | [4-[3-(ethylamino)-2-pyridyl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone;methanesulfonic acid | Atevirdine mesylate | 475.60 |
| C21H25N5O2 | [4-[3-(ethylamino)-2-pyridyl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone | Atevirdine | 379.50 |
| C30H33Cl2F2N5O2 | 1-[2-(4-amino-2,6-dichloro-anilino)-2-oxo-ethyl]-4-[5,5-bis(4-fluorophenyl)pentyl]piperazine-2-carboxamide | Draflazine | 604.50 |
| C16H28N5O9-3 | 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;hydrate | 138721-73-0 | 434.42 |
| C9H22NNaO7P2 | sodium hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphinate | sodium hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphinate | 341.21 |
| C9H23NO7P2 | [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphonic acid | Ibandronic Acid | 319.23 |
| C21H24Cl2N4O2S | 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one;hydrate;hydrochloride | 138982-67-9 | 467.40 |